May 10, 2017 by Brian Feroldi, Travis Hoium, and Demitri Kalogeropoulos3 Dividend Stocks for Successful InvestorsAre you looking for a few stocks that can help you protect your nest egg? Here's why you should consider Church & Dwight, Las Vegas Sands, and Sherwin-Williams.
May 9, 2017 by Brian FeroldiHere's Why Diplomat Pharmacy Inc. Is Rising TodayTraders responded positively to the company's first-quarter earnings report.
May 9, 2017 by Brian FeroldiNovavax, Inc Is Rising Today, but You Should Still Stay Far AwayShareholders cheered the company's first-quarter earnings report, but there are still plenty of reasons to steer clear of this stock.
May 9, 2017 by Brian Feroldi, Rich Smith, and Matt DiLallo3 Top Dividend Aristocrats for MayAre you on the hunt for a few reliable dividend payers? Here's why you should put ExxonMobil, Ecolab, and Nucor on your shopping list.
May 8, 2017 by Brian FeroldiWhy Acceleron Pharma Inc. Is Tumbling TodayShares drop after the company's first-quarter earnings results came up short of expectations.
May 8, 2017 by Brian FeroldiHere's Why TherapeuticsMD Inc. Stock Is Sinking TodayShares are tumbling after news broke that the FDA has rejected its application for Yuvvexy.
May 8, 2017 by Brian FeroldiHorizon Global Corp. Reports Another Loss but Raises Full-Year Profit GuidanceAcquisitions allowed the towing equipment provider's revenue to surge yet again, but higher spending took its toll on the company's profits.
May 7, 2017 by Brian FeroldiI'm Already Up Over 200% on the Next Intuitive SurgicalThis sub-$1 billion company is following in the footsteps of Intuitive Surgical and has already produced multibagger returns for early investors like me.
May 5, 2017 by Brian FeroldiInfinera's Earnings: Revenue Tumbles Yet Again as Near-Term Challenges PersistInfinera reported yet another quarter of falling sales, and expects more of the same ahead.
May 5, 2017 by Brian FeroldiAbiomed, Inc. Pumps Out 33% Revenue GrowthSales of the Impella family of heart pumps continue to grow rapidly, driving margin improvements and big gains on the bottom line.
May 5, 2017 by Brian FeroldiHere's Why ArtiCure, Inc. Is Up Double-Digits TodayBetter-than-expected first-quarter results caused ArtiCure's stock to jump.
May 4, 2017 by Brian FeroldiFormFactor, Inc. Kicks Off 2017 on a High NoteFormFactor's first-quarter results handily beat its own guidance, and management provided investors with a bullish outlook.
May 4, 2017 by Brian FeroldiPaycom Software, Inc Kicks Off 2017 on a High NoteThe human capital management specialist once again posted meaningful gains in revenue and profits.
May 4, 2017 by Brian FeroldiWhy FormFactor, Inc. Is Soaring TodayBetter-than-expected quarterly results mixed with a bullish outlook cause FormFactor's stock to jump.
May 4, 2017 by Brian FeroldiQuintiles IMS Holdings Starts 2017 StrongThe healthcare and life sciences service provider reports first-quarter results that came in ahead of guidance.
May 3, 2017 by Brian FeroldiWhy VWR Corp. Is Soaring TodayNews that a buyout could be in the works causes VWR's share price to spike.
May 3, 2017 by Brian FeroldiHere's Why Molina Healthcare, Inc. Is Rising AgainShares rally for the second day in a row after the company reports upbeat first-quarter results.
May 3, 2017 by Brian FeroldiHere's Why DexCom Stock Is Tanking TodayShares dropped after the glucose-monitoring specialist's first-quarter revenue came up a bit short of expectations.
May 3, 2017 by Brian FeroldiHere's Why Frontier Communications Corporation Is PlungingShares nose-dive after the company reports disappointing quarterly results and significantly cuts its overly generous dividend payment.
May 3, 2017 by Brian FeroldiHere's Why ImmunoGen Rose 10.7% in AprilIt was a quiet month for the beleaguered biotech, but a few actions by Wall Street analysts caused the share price to climb by double digits.
